BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7641572)

  • 1. Dapsone-induced hemolytic anemia.
    Jollow DJ; Bradshaw TP; McMillan DC
    Drug Metab Rev; 1995; 27(1-2):107-24. PubMed ID: 7641572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of lipid peroxidation in dapsone-induced hemolytic anemia.
    McMillan DC; Jensen CB; Jollow DJ
    J Pharmacol Exp Ther; 1998 Dec; 287(3):868-76. PubMed ID: 9864266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dapsone-induced hemolytic anemia: effect of dapsone hydroxylamine on sulfhydryl status, membrane skeletal proteins and morphology of human and rat erythrocytes.
    McMillan DC; Simson JV; Budinsky RA; Jollow DJ
    J Pharmacol Exp Ther; 1995 Jul; 274(1):540-7. PubMed ID: 7616443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia.
    Grossman SJ; Jollow DJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):118-25. PubMed ID: 3335994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dapsone-induced hemolytic anemia: effect of N-hydroxy dapsone on the sulfhydryl status and membrane proteins of rat erythrocytes.
    Grossman SJ; Simson J; Jollow DJ
    Toxicol Appl Pharmacol; 1992 Dec; 117(2):208-17. PubMed ID: 1471153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dapsone-induced hemolytic anemia: role of glucose-6-phosphate dehydrogenase in the hemolytic response of rat erythrocytes to N-hydroxydapsone.
    Grossman S; Budinsky R; Jollow D
    J Pharmacol Exp Ther; 1995 May; 273(2):870-7. PubMed ID: 7752092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primaquine-induced hemolytic anemia: effect of 6-methoxy-8-hydroxylaminoquinoline on rat erythrocyte sulfhydryl status, membrane lipids, cytoskeletal proteins, and morphology.
    Bolchoz LJ; Morrow JD; Jollow DJ; McMillan DC
    J Pharmacol Exp Ther; 2002 Oct; 303(1):141-8. PubMed ID: 12235244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methemoglobin formation by hydroxylamine metabolites of sulfamethoxazole and dapsone: implications for differences in adverse drug reactions.
    Reilly TP; Woster PM; Svensson CK
    J Pharmacol Exp Ther; 1999 Mar; 288(3):951-9. PubMed ID: 10027831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of free radicals and protein mixed disulfides in rat red cells exposed to dapsone hydroxylamine.
    Bradshaw TP; McMillan DC; Crouch RK; Jollow DJ
    Free Radic Biol Med; 1997; 22(7):1183-93. PubMed ID: 9098092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of K-C1 cotransport in rat red cells by a hemolytic anemia-producing metabolite of dapsone.
    Haas M; Harrison JH
    Am J Physiol; 1989 Feb; 256(2 Pt 1):C265-72. PubMed ID: 2919657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primaquine-induced hemolytic anemia: formation of free radicals in rat erythrocytes exposed to 6-methoxy-8-hydroxylaminoquinoline.
    Bolchoz LJ; Gelasco AK; Jollow DJ; McMillan DC
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1121-9. PubMed ID: 12438535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dapsone-induced hematologic toxicity: comparison of the methemoglobin-forming ability of hydroxylamine metabolites of dapsone in rat and human blood.
    Vage C; Saab N; Woster PM; Svensson CK
    Toxicol Appl Pharmacol; 1994 Dec; 129(2):309-16. PubMed ID: 7992320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primaquine-induced hemolytic anemia: role of membrane lipid peroxidation and cytoskeletal protein alterations in the hemotoxicity of 5-hydroxyprimaquine.
    Bowman ZS; Morrow JD; Jollow DJ; McMillan DC
    J Pharmacol Exp Ther; 2005 Aug; 314(2):838-45. PubMed ID: 15840764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine.
    Bowman ZS; Oatis JE; Whelan JL; Jollow DJ; McMillan DC
    J Pharmacol Exp Ther; 2004 Apr; 309(1):79-85. PubMed ID: 14724225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxylamine treatment increases glutathione-protein and protein-protein binding in human erythrocytes.
    Spooren AA; Evelo CT
    Blood Cells Mol Dis; 1997 Dec; 23(3):323-36. PubMed ID: 9398534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive oxygen species generation and its role in the differential cytotoxicity of the arylhydroxylamine metabolites of sulfamethoxazole and dapsone in normal human epidermal keratinocytes.
    Vyas PM; Roychowdhury S; Woster PM; Svensson CK
    Biochem Pharmacol; 2005 Jul; 70(2):275-86. PubMed ID: 15894292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline.
    Bolchoz LJ; Budinsky RA; McMillan DC; Jollow DJ
    J Pharmacol Exp Ther; 2001 May; 297(2):509-15. PubMed ID: 11303037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress, glucose-6-phosphate dehydrogenase and the red cell.
    Jollow DJ; McMillan DC
    Adv Exp Med Biol; 2001; 500():595-605. PubMed ID: 11765001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dapsone Hydroxylamine, an Active Metabolite of Dapsone, Can Promote the Procoagulant Activity of Red Blood Cells and Thrombosis.
    Bian Y; Kim K; An GJ; Ngo T; Bae ON; Lim KM; Chung JH
    Toxicol Sci; 2019 Dec; 172(2):435-444. PubMed ID: 31428780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoacetyldapsone inhibition of dapsone N-hydroxylation by human and rat liver microsomes.
    Irshaid Y; Adedoyin A; Lotze M; Branch RA
    Drug Metab Dispos; 1994; 22(1):161-4. PubMed ID: 8149877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.